These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 7195139)

  • 21. A cross-sectional study of haemolytic disease of the newborn in Uganda.
    Dhabangi A; Nankunda J; Okaba V; Nakubulwa S; Hume HA; Dzik WH; Heddle NM
    Vox Sang; 2022 Dec; 117(12):1398-1404. PubMed ID: 36342344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A study on diagnostic performance of different immunohematological diagnostic tests in assessing the prevalence of ABO Hemolytic Disease of Newborn in the antenatal O group mothers and their neonatal outcome in a tertiary care hospital in Northern India.
    Deb J; Jain A; Kaur D; Bahadur A; Basu S; Negi G
    Transfus Apher Sci; 2024 Feb; 63(1):103864. PubMed ID: 38135544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complement is not activated in ABO-haemolytic disease of the newborn.
    Brouwers HA; Overbeeke MA; Huiskes E; Bos MJ; Ouwehand WH; Engelfriet CP
    Br J Haematol; 1988 Mar; 68(3):363-6. PubMed ID: 3258530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Direct antiglobulin reaction in ABO-haemolytic disease of the newborn.
    Romano EL; Hughes-Jones NC; Mollison PL
    Br Med J; 1973 Mar; 1(5852):524-6. PubMed ID: 4540300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Correlation of newborn hemolytic disease with ABO antibodies in sera of pregnant women].
    Yang SM; Wu QY; Luo HQ; Lan JC
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):875-7. PubMed ID: 16277862
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prediction of the development of neonatal hyperbilirubinemia in ABO incompatibility.
    Chen JY; Ling UP
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Jan; 53(1):13-8. PubMed ID: 8173995
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An early (sixth-hour) serum bilirubin measurement is useful in predicting the development of significant hyperbilirubinemia and severe ABO hemolytic disease in a selective high-risk population of newborns with ABO incompatibility.
    Sarici SU; Yurdakök M; Serdar MA; Oran O; Erdem G; Tekinalp G; Yiğit S
    Pediatrics; 2002 Apr; 109(4):e53. PubMed ID: 11927726
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A detailed serological study on the prediction and diagnosis of ABO haemolytic disease of the newborn (ABO HD).
    Voak D; Bowley CC
    Vox Sang; 1969 Nov; 17(5):321-48. PubMed ID: 5308005
    [No Abstract]   [Full Text] [Related]  

  • 29. Case Report: First Case of Cefotaxime-Sulbactam-Induced Acute Intravascular Hemolysis in a Newborn With ABO Blood Type Incompatibility by the Mechanism of Non-Immunologic Protein Adsorption.
    Wu Y; Wu Y; Yang Y; Chen B; Li J; Guo G; Xiong F
    Front Immunol; 2021; 12():698541. PubMed ID: 35003054
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Detection and analysis of ABO Hemolytic disease in newborn].
    Lin ZX; Dong QS
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1432-4. PubMed ID: 25338602
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ABO incompatibility due to immunoglobulin G anti-B antibodies presenting with severe fetal anaemia.
    Ziprin JH; Payne E; Hamidi L; Roberts I; Regan F
    Transfus Med; 2005 Feb; 15(1):57-60. PubMed ID: 15713130
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Revisiting ABO incompatibility as a risk factor for significant neonatal hyperbilirubinemia.
    Khurana R; Batra P; Faridi M; Khan N
    Trop Doct; 2019 Jul; 49(3):201-204. PubMed ID: 30943888
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A case of neonatal ABO immunization which was difficult to diagnose. The mother with blood group A2 and the infant with negative direct antiglobulin test].
    Kumlien G; Sarman I; Shanwell A
    Lakartidningen; 2000 Sep; 97(38):4138-40. PubMed ID: 11068380
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transfusion support in the management of immune haemolytic disorders.
    Plapp FV; Beck ML
    Clin Haematol; 1984 Feb; 13(1):167-83. PubMed ID: 6327130
    [No Abstract]   [Full Text] [Related]  

  • 35. An unusual case of ABO-haemolytic disease of the newborn.
    Haque KM; Rahman M
    Bangladesh Med Res Counc Bull; 2000 Aug; 26(2):61-4. PubMed ID: 11508073
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Direct enzyme linked antiglobulin tests (ELAT) for detecting in-vivo sensitized erythrocytes: evaluation of screening for ABO incompatibility of newborn.
    Kiruba R; Ong R; Han P
    Pathology; 1988 Apr; 20(2):147-51. PubMed ID: 3211591
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Value of measuring cord blood bilirubin concentration in ABO incompatibility.
    Haque KN
    Br Med J; 1978 Dec; 2(6152):1604. PubMed ID: 569526
    [No Abstract]   [Full Text] [Related]  

  • 38. Incidence of ABO haemolytic disease of the newborn in a group of Hong Kong babies with severe neonatal jaundice.
    Feng CS; Wan CP; Lau J; Lam TK; Fok TF
    J Paediatr Child Health; 1990 Jun; 26(3):155-7. PubMed ID: 2206617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma fibrinogen concentration in ABO-hemolytic disease of the newborn.
    Romano EL; Linares J; Suárez G
    Int Arch Allergy Appl Immunol; 1982; 67(1):74-7. PubMed ID: 7199030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of high risk pregnancies with relation to ABO haemolytic disease of newborn.
    Usha KK; Sulochana PV
    Indian J Pediatr; 1998; 65(6):863-5. PubMed ID: 10773951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.